UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000036511
Receipt No. R000041594
Scientific Title Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy
Date of disclosure of the study information 2019/05/07
Last modified on 2019/04/15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy
Acronym Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy
Scientific Title Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy
Scientific Title:Acronym Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy
Region
Japan

Condition
Condition Patients who undergo pancreatoduodenectomy for peri-pancreatic tumors such as pancreatic cancers or lower bile duct cancers
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The objective of this study to compare prospectively the efficacy of K-2S plus as enteral nutrients after pancreatoduodenectomy to that of ELENTAL.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Defecation frequency
Fecal condition (Bristol scale)
Key secondary outcomes Weight loss rate
Lymphocyte count and reduction rate
Serum albumin level and reduction rate
Serum prealbumin (transthyretin) levels and reduction rates
Postoperative complication rate (Clavian-Dindo IIIa or more)
Enteral nutrition protocol completion rate
Enteral nutrition protocol total administered calories
Total calories required after enteral feeding protocol

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Food
Interventions/Control_1 Patients who will undergo PD will be prospectively registered and assigned to K-2S plus group from patients who have started registration. When the number of cases in the K-2S plus group reaches 20, the assignment to the K-2S plus group ends.
Interventions/Control_2 Cases in which IC of K-2S plus administration can not be obtained will be assigned to the Elental group. After the K-2S plus group reached 20 cases, all were assigned to the Elenthal group, and when the Elental group reached 20 cases, the entire assignment was completed.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) Cases where the age of registration date is over 20 years old
(2) PS (ECOG) 0 or 1 case
(3) Cases that meet all the following conditions
For all test items, the latest value is used within 14 days before surgery (a test on the same day two weeks before the registration date is acceptable).
1) White blood cells> or more 4,000 and < or less 12,000.
2) Neutrophil> or more 2,000.
3) Platelets> or more 100,000.
4) Hemoglobin> or more 8.0.
5) AST< or less 100.
6) ALT< or less 100.
7) Total bilirubin< or less 1.2.
8) Serum creatinine< or less 1.2.
(4) Cases that can be taken orally (Dysphagia score< or less 1).
Key exclusion criteria (1) Patients who are contraindicated with K-2S plus or Erental
1) A case with allergies to eggs, dairy products and soy
2) A case with hypersensitivity to K-2S plus
3) A case with hypersensitivity to Ellenthal
4) A case with amino acid metabolism disorder
(2) Cases with active bacterial and fungal infections (cases with fever above 38 degree and cases where bacterial infection has been shown by imaging or bacteriological examination).
(3) A case that is complicated by psychosis or psychiatric symptoms and difficult to participate in this study.
(4) Cases that the study responsible (share) physician judged inappropriate for this study
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Hideo
Middle name
Last name Baba
Organization Graduate School of Medical Sciences,
Kumamoto University
Division name Department of Gastroenterological Surgery
Zip code 860-8556
Address 1-1-1, Honjo, Chuo-ku, Kumamoto
TEL 096-373-5211
Email hdobaba@kumamoto-u.ac.jp

Public contact
Name of contact person
1st name Yo-ichi
Middle name
Last name Yamashita
Organization Graduate School of Medical Sciences, Kumamoto University
Division name Department of Gastroenterological Surgery
Zip code 860-8556
Address 1-1-1, Honjo, Chuo-ku, Kumamoto
TEL 096-373-5211
Homepage URL
Email y-yama@kumamoto-u.ac.jp

Sponsor
Institute Kumamoto University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kumamoto University Hospital
Address 1-1-1, Honjo, Chuo-ku, Kumamoto
Tel 096-373-5966
Email byi-senshin@jimu.kumamoto-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 05 Month 07 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 04 Month 15 Day
Date of IRB
Anticipated trial start date
2019 Year 05 Month 07 Day
Last follow-up date
2021 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 04 Month 15 Day
Last modified on
2019 Year 04 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041594

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.